相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The impact of intragenic CpG content on gene expression
Asli Petra Bauer et al.
NUCLEIC ACIDS RESEARCH (2010)
Nonviral Gene Delivery: Principle, Limitations, and Recent Progress
Mohammed S. Al-Dosari et al.
AAPS JOURNAL (2009)
Effect of the content of unmethylated CpG dinucleotides in plasmid DNA on the sustainability of transgene expression
Masaru Mitsui et al.
JOURNAL OF GENE MEDICINE (2009)
Therapy of anemia in kidney failure, using plasmid encoding erythropoietin
Peggy Richard-Fiardo et al.
HUMAN GENE THERAPY (2008)
Effects of inflammatory response on in vivo transgene expression by plasmid DNA in mice
Keiko Kako et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Rational vector design for efficient non-viral gene delivery: Challenges facing the use of plasmid DNA
Juergen Mairhofer et al.
MOLECULAR BIOTECHNOLOGY (2008)
Advances in high-capacity extrachromosomal vector technology: Episomal maintenance, vector delivery, and transgene expression
Michele M. P. Lufino et al.
MOLECULAR THERAPY (2008)
CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression
Stephen C. Hyde et al.
NATURE BIOTECHNOLOGY (2008)
Plasmid CpG depletion improves degree and duration of tumor gene expression after intravenous administration of polyplexes
Holger K. de Wolf et al.
PHARMACEUTICAL RESEARCH (2008)
Gene expression profiles in skeletal muscle after gene electrotransfer
Pernille Hojman et al.
BMC MOLECULAR BIOLOGY (2007)
Sensitive and precise regulation of haemoglobin after gene transfer of erythropoietin to muscle tissue using electroporation
P. Hojman et al.
GENE THERAPY (2007)
Progress toward a nonviral gene therapy protocol for the treatment of anemia
Magdolna G. Sebestyen et al.
HUMAN GENE THERAPY (2007)
Plasmid engineering for controlled and sustained gene expression for nonviral gene therapy
Ethlinn V. B. van Gaal et al.
PHARMACEUTICAL RESEARCH (2006)
Gene therapy progress and prospects: Recent progress in transgene and RNAi expression cassettes
CR Ill et al.
GENE THERAPY (2005)
Controlling the kinetics of transgene expression by plasmid design
NS Yew
ADVANCED DRUG DELIVERY REVIEWS (2005)
Towards safe, non-viral therapeutic gene expression in humans
DJ Glover et al.
NATURE REVIEWS GENETICS (2005)
EGFP reporter genes silence LCRβ-globin transgene expression via CpG dinucleotides
B Dalle et al.
MOLECULAR THERAPY (2005)
Long-term pharmacologically regulated expression of erythropoietin in,primates following AAV-mediated gene transfer
VM Rivera et al.
BLOOD (2005)
Gene electro-transfer of an improved erythropoietin plasmid in mice and non-human primates
E Fattori et al.
JOURNAL OF GENE MEDICINE (2005)
Erythropoietin gene therapy leads to autoimmune anemia in macaques
GP Gao et al.
BLOOD (2004)
Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo
ZY Chen et al.
GENE THERAPY (2004)
Autoimmune anemia in macaques following erythropoietin gene therapy
P Chenuaud et al.
BLOOD (2004)
Long-term transgene expression from plasmid DNA gene therapy vectors is negatively affected by CpG dinucleotides
BL Hodges et al.
MOLECULAR THERAPY (2004)
Codon bias and heterologous protein expression
C Gustafsson et al.
TRENDS IN BIOTECHNOLOGY (2004)
In vivo gene electrotransfer into skeletal muscle:: effects of plasmid DNA on the occurrence and extent of muscle damage
AC Durieux et al.
JOURNAL OF GENE MEDICINE (2004)
Optimization of ectopic gene expression in skeletal muscle through DNA transfer by electroporation
J Taylor et al.
BMC BIOTECHNOLOGY (2004)
Mammalian mutation pressure, synonymous codon choice, and mRNA degradation
JB Duan et al.
JOURNAL OF MOLECULAR EVOLUTION (2003)
CpG content affects gene silencing in mice: evidence from novel transgenes
C Chevalier-Mariette et al.
GENOME BIOLOGY (2003)
Ligand-regulatable erythropoietin production by plasmid injection and in vivo electroporation
Y Terada et al.
KIDNEY INTERNATIONAL (2002)
CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo
NS Yew et al.
MOLECULAR THERAPY (2002)
Nonviral approaches satisfying various requirements for effective in vivo gene therapy
M Nishikawa et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2002)
Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: Plasmid dependence of muscle damage and effect of poloxamer 188
J Hartikka et al.
MOLECULAR THERAPY (2001)
Methylation of episomal plasmids as a barrier to transient gene expression via a synthetic delivery vector
K Hong et al.
BIOMOLECULAR ENGINEERING (2001)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
Improvement of mouse β-thalassemia by electrotransfer of erythropoietin cDNA
E Payen et al.
EXPERIMENTAL HEMATOLOGY (2001)
Long-term production of erythropoietin after electroporation-mediated transfer of plasmid DNA into the muscles of normal and uremic rats
H Maruyama et al.
GENE THERAPY (2001)
The role of CpG motifs in immunostimulation and gene therapy
RK Scheule
ADVANCED DRUG DELIVERY REVIEWS (2000)
Prolonged expression and effective readministration of erythropoietin delivered with a fully deleted adenoviral vector
D Maione et al.
HUMAN GENE THERAPY (2000)
A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy
D Miklavcic et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2000)
Regulated gene expression systems
T Clackson
GENE THERAPY (2000)
分享论文
